# SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
Canonical URL: https://biopharmsignal.com/news/SIBN/si-bone-to-present-at-truist-securities-2026-medtech-conference-on-june-16-2026
Ticker: SIBN
Company: Si-Bone
Source: Si-Bone
Published: 2026-06-25 13:46 EST
Original Source URL: https://investor.si-bone.com
## Summary

SANTA CLARA, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming 2026 Truist Securities

## Article Body
SANTA CLARA, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming 2026 Truist Securities
## Recent Company News
- 2026-06-25 13:46 EST — [SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026](https://biopharmsignal.com/news/SIBN/si-bone-to-present-at-truist-securities-2026-medtech-conference-on-june-16-2026) — Source: Si-Bone
- 2026-06-25 13:46 EST — [SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance](https://biopharmsignal.com/news/SIBN/si-bone-inc-reports-financial-results-for-the-first-quarter-2026-and-raises-2026-guidance) — Source: Si-Bone
- 2026-06-25 13:46 EST — [SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025](https://biopharmsignal.com/news/SIBN/si-bone-to-present-at-morgan-stanley-23rd-global-healthcare-conference-on-september-9-2025) — Source: Si-Bone
- 2026-06-25 13:46 EST — [SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025](https://biopharmsignal.com/news/SIBN/si-bone-to-report-third-quarter-2025-financial-results-on-november-10-2025) — Source: Si-Bone
- 2026-06-25 13:46 EST — [SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance](https://biopharmsignal.com/news/SIBN/si-bone-inc-reports-financial-results-for-the-third-quarter-2025-and-raises-2025-guidance) — Source: Si-Bone
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)